Liang Xiujie, Potenza Duilio Michele, Brenna Andrea, Ma Yiqiong, Ren Zhilong, Cheng Xin, Ming Xiu-Fen, Yang Zhihong
Laboratory of Cardiovascular and Aging Research, Department of Endocrinology, Metabolism, and Cardiovascular System, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
Front Physiol. 2021 Nov 19;12:773719. doi: 10.3389/fphys.2021.773719. eCollection 2021.
The ureohydrolase, type-II arginase (Arg-II), is a mitochondrial enzyme metabolizing L-arginine into urea and L-ornithine and is highly expressed in renal proximal tubular cells (PTC) and upregulated by renal ischemia. Recent studies reported contradictory results on the role of Arg-II in renal injury. The aim of our study is to investigate the function of Arg-II in renal epithelial cell damage under hypoxic conditions. Human renal epithelial cell line HK2 was cultured under hypoxic conditions for 12-48 h. Moreover, experiments with isolated kidneys from wild-type (WT) and genetic Arg-II deficient mice ( ) were conducted under normoxic and hypoxic conditions. The results show that hypoxia upregulates Arg-II expression in HK2 cells, which is inhibited by silencing both hypoxia-inducible factors (HIFs) HIF1α and HIF2α. Treatment of the cells with dimethyloxaloylglycine (DMOG) to stabilize HIFα also enhances Arg-II. Interestingly, hypoxia or DMOG upregulates transforming growth factor β1 (TGFβ1) levels and α, which is prevented by silencing, while TGFβ1-induced α expression is not affected by silencing. Inhibition of mitochondrial complex-I by rotenone abolishes hypoxia-induced reactive oxygen species (mtROS) and TGFβ1 elevation in the cells. experiments show elevated Arg-II and TGFβ1 expression and the injury marker NGAL in the WT mouse kidneys under hypoxic conditions, which is prevented in the mice. Taking together, the results demonstrate that hypoxia activates renal epithelial HIFs-Arg-II-mtROS-TGFβ1-cascade, participating in hypoxia-associated renal injury and fibrosis.
脲水解酶,即II型精氨酸酶(Arg-II),是一种线粒体酶,可将L-精氨酸代谢为尿素和L-鸟氨酸,在肾近端小管细胞(PTC)中高度表达,并在肾缺血时上调。最近的研究报告了关于Arg-II在肾损伤中的作用的相互矛盾的结果。我们研究的目的是探讨Arg-II在缺氧条件下肾上皮细胞损伤中的功能。将人肾上皮细胞系HK2在缺氧条件下培养12 - 48小时。此外,在常氧和缺氧条件下对野生型(WT)和基因敲除Arg-II的小鼠的离体肾脏进行实验。结果表明,缺氧上调HK2细胞中Arg-II的表达,而通过沉默缺氧诱导因子(HIFs)HIF1α和HIF2α可抑制这种上调。用二甲基乙二酰甘氨酸(DMOG)处理细胞以稳定HIFα也会增强Arg-II。有趣的是,缺氧或DMOG上调转化生长因子β1(TGFβ1)水平和α,沉默可阻止这种上调,而TGFβ1诱导的α表达不受沉默的影响。鱼藤酮抑制线粒体复合物I可消除缺氧诱导的细胞内活性氧(mtROS)和TGFβ1升高。实验表明,在缺氧条件下,WT小鼠肾脏中Arg-II和TGFβ1表达以及损伤标志物中性粒细胞明胶酶相关脂质运载蛋白(NGAL)升高,而在基因敲除小鼠中则可防止这种情况。综上所述,结果表明缺氧激活肾上皮HIFs-Arg-II-mtROS-TGFβ1级联反应,参与缺氧相关的肾损伤和纤维化。